ClinicalTrials.gov
public full text
Public Domain
Study of SANGUINATE™ Versus Hydroxyurea in Sickle Cell Disease (SCD) Patients
The purpose of this study is to compare the safety of SANGUINATE™ versus Hydroxyurea in patients suffering from Sickle Cell Disease.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Hydroxyurea and EPO in Sickle Cell Disease#840610
- Hydroxyurea and Transfusion#857483
- Evaluation of the Impact of Renal Function on the Pharmacokinetics of SIKLOS ® (DARH)#1047426
- Acute Kidney Injury in Patients With Sickle Cell Disease#880541
- Effect of NUV001 Supplementation in Patients Suffering From Sickle Cell Disease (SCD)#995349
Record · ID 813640
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive